Literature DB >> 15467907

Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood.

Nelli Baal1, Kerstin Reisinger, Henning Jahr, Rainer M Bohle, Olin Liang, Karsten Münstedt, C V Rao, Klaus T Preissner, Marek T Zygmunt.   

Abstract

A significant number of hematopoietic stem/progenitor cells (HSPC) in human umbilical cord blood could serve as a reservoir for the placental vasculature, yet, their morphological and functional features are not completely understood. Here, we describe the characterization of purified CD133(+) progenitor cells from umbilical cord blood, a subset of CD34(+) hematopoietic progenitors that were grown in proliferation medium containing Flt3-ligand, thrombopoietin and stem cell factor. Following isolation and enrichment of the CD133(+) cells by immunomagnetic cell sorting, they remained non-adherent for up to 40 days in culture and expressed different pluripotency markers including Sox-1, Sox-2, FGF-4, Rex-1 and Oct-4.Oct-4 expression was confirmed by laser-assisted single cell picking with subsequent quantitative real-time RT-PCR. The expression of Oct-4 indicates a pluripotent phenotype of CD133(+) cells and appears to be of functional relevance: After three weeks in endothelial differentiation medium, suspended cells became adherent, developed an endothelial cell-like morphology, bound fluoresceine isothiocyanate-labeled Ulex europaeus agglutinin-1, took up acetylated Di-LDL, and expressed other endothelial markers such as PECAM-1 or VEGFR-2. Concomitantly, Oct-4 expression was significantly reduced. Moreover, following treatment with retinoic acid, CD133(+) cells exhibited neural morphology associated with the expression of beta-III-tubulin. CD133(+) cells were found to express the luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor, detected by RT-PCR and immunocytochemistry. The recombinant human chorionic gonadotropin induced proliferation of the CD133(+) cells in a dose-specific manner. Our results indicate that CD133(+) HSPC from umbilical cord blood may have a greater differentiation potential than previously recognized and give rise to proliferative endothelial cells participating in placental vasculogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467907     DOI: 10.1160/TH04-02-0079

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life.

Authors:  L Qiu; H P Low; C-I Chang; W C Strohsnitter; M Anderson; K Edmiston; H-O Adami; A Ekbom; P Hall; P Lagiou; D Trichopoulos; C-C Hsieh
Journal:  Ann Oncol       Date:  2011-04-22       Impact factor: 32.976

2.  Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells.

Authors:  M C Barsotti; A Magera; C Armani; F Chiellini; F Felice; D Dinucci; A M Piras; A Minnocci; R Solaro; G Soldani; A Balbarini; R Di Stefano
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

3.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

4.  Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny.

Authors:  M Howe; J Zhao; Y Bodenburg; C P McGuckin; N Forraz; R G Tilton; R J Urban; L Denner
Journal:  Cell Prolif       Date:  2009-03-25       Impact factor: 6.831

Review 5.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

6.  Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells.

Authors:  Carol Tucker-Burden; Prasanthi Chappa; Malini Krishnamoorthy; Brian A Gerwe; Christopher D Scharer; Jamie Heimburg-Molinaro; Wayne Harris; Sümeyra Naz Usta; Carmen D Eilertson; Constantinos G Hadjipanayis; Steven L Stice; Daniel J Brat; Rodney J Nash
Journal:  Stem Cells Dev       Date:  2012-04-27       Impact factor: 3.272

7.  OCT4 pseudogenes present in human leukemia cells.

Authors:  Xiaoping Guo; Yongmin Tang
Journal:  Clin Exp Med       Date:  2011-11-16       Impact factor: 3.984

8.  Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.

Authors:  Zoe Redshaw; Alastair J Strain
Journal:  J Negat Results Biomed       Date:  2010-03-31

9.  Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

Authors:  Zia A Khan; Elisa Boscolo; Arnaud Picard; Sarah Psutka; Juan M Melero-Martin; Tatianna C Bartch; John B Mulliken; Joyce Bischoff
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  Regulation of adipose tissue stromal cells behaviors by endogenic Oct4 expression control.

Authors:  Jung Hwan Kim; Min Ki Jee; So Young Lee; Tae Hee Han; Bong Sun Kim; Kyung Sun Kang; Soo Kyung Kang
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.